#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    X-linked lymphoproliferative syndrome Uveitis Multiple system atrophy Diffuse large B-cell lymphoma recurrent Central nervous system lymphoma Osteosarcoma recurrent Metabolic disorder Ventricular fibrillation Waldenstrom's macroglobulinaemia recurrent Leukodystrophy Cutaneous calcification Leukoencephalopathy Atypical haemolytic uraemic syndrome Liver abscess Ovarian cancer More trials…

    Learn about Rare Diseases

    Pelizaeus-Merzbacher disease – Life with Disease Mantle cell lymphoma stage II – Trials in Disease Pulmonary sarcoidosis – Trials in Disease Osteosarcoma – Treatment Hairy cell leukaemia – Treatment Bronchiolitis obliterans syndrome – Diagnostics Acquired haemophilia – Treatment Sjogren’s syndrome Gastrointestinal stromal tumour – Treatment Combined immunodeficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexlansoprazole Gemtuzumab Ozogamicin IMELASOMERAN Xenon Dupilumab Tranexamic Acid Gs-5718-03 Levocabastine Hydrochloride Eptacog Beta (Activated) Lifileucel ENSIFENTRINE Riliprubart ALN-4324 Opevesostat H2-Receptor Antagonists Vudalimab Pegargiminase SALICYLIC ACID OMEGA-3-ACID ETHYL ESTERS 90 Tucatinib More therapies…

    Learn about Your Condition

    Femur fracture Kawasaki's disease Hepatic adenoma Myocarditis post infection End stage renal disease Metachromatic leukodystrophy Pneumothorax Streptococcal infection Nasal sinus cancer Chronic coronary syndrome Hypersomnia Polycystic ovarian syndrome Pneumonia bacterial Carotid artery occlusion Behavioural addiction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of A Coruna

University Of A Coruna

Calle Maestranza 9, A Coruna Galicia, 15001, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study of CIT-013 at Three Different Doses for Patients with Moderately Active Rheumatoid Arthritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Sodium Chloride
    Belgium Germany The Netherlands Poland Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!